These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 7300508)

  • 1. [Immunologic response of mice to influenza virus strains with different neuraminidase activity].
    Loza-Tulimowska M; Brydak L
    Med Dosw Mikrobiol; 1981; 33(2):119-22. PubMed ID: 7300508
    [No Abstract]   [Full Text] [Related]  

  • 2. Beta 2-microglobulin-deficient mice can be protected against influenza A infection by vaccination with vaccinia-influenza recombinants expressing hemagglutinin and neuraminidase.
    Epstein SL; Misplon JA; Lawson CM; Subbarao EK; Connors M; Murphy BR
    J Immunol; 1993 Jun; 150(12):5484-93. PubMed ID: 8390536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Course of influenza virus adaptation to immunized and immunosuppressed mice].
    Loza-Tulimowska M; Wilczyński J
    Med Dosw Mikrobiol; 1981; 33(2):133-40. PubMed ID: 7300511
    [No Abstract]   [Full Text] [Related]  

  • 4. Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain.
    de Wit E; Munster VJ; Spronken MI; Bestebroer TM; Baas C; Beyer WE; Rimmelzwaan GF; Osterhaus AD; Fouchier RA
    J Virol; 2005 Oct; 79(19):12401-7. PubMed ID: 16160167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization against influenza A virus: comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system.
    Brett IC; Johansson BE
    Virology; 2005 Sep; 339(2):273-80. PubMed ID: 15996702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TH cells primed during influenza virus infection provide help for qualitatively distinct antibody responses to subsequent immunization.
    Marshall D; Sealy R; Sangster M; Coleclough C
    J Immunol; 1999 Nov; 163(9):4673-82. PubMed ID: 10528164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuraminidase antibodies and H5N1: geographic-dependent influenza epidemiology could determine cross-protection against emerging strains.
    Bermejo-Martin JF; Kelvin DJ; Guan Y; Chen H; Perez-Breña P; Casas I; Arranz E; de Lejarazu RO
    PLoS Med; 2007 Jun; 4(6):e212. PubMed ID: 17593897
    [No Abstract]   [Full Text] [Related]  

  • 8. [Viral characteristics and immunologic reactions of the body during adaptation of influenza virus type A to mice. II. Immunologic reactions].
    Loza-Tulimowska M
    Med Dosw Mikrobiol; 1984; 36(1):45-53. PubMed ID: 6330474
    [No Abstract]   [Full Text] [Related]  

  • 9. Protection afforded by intranasal immunization with the neuraminidase-lacking mutant of influenza A virus in a ferret model.
    Mishin VP; Nedyalkova MS; Hayden FG; Gubareva LV
    Vaccine; 2005 Apr; 23(22):2922-7. PubMed ID: 15780741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation and evaluation of an H9N1 influenza vaccine derived by reverse genetics that allows utilization of a DIVA strategy for control of H9N2 avian influenza.
    Wu R; Chen Q; Zheng L; Chen J; Sui Z; Guan Y; Chen Z
    Arch Virol; 2009; 154(8):1203-10. PubMed ID: 19543688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A protective immune response in mice to viral components other than hemagglutinin in a live influenza A virus vaccine model.
    Horimoto T; Takada A; Iwatsuki-Horimoto K; Kawaoka Y
    Vaccine; 2004 Jun; 22(17-18):2244-7. PubMed ID: 15149783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection of mice with recombinant influenza virus neuraminidase.
    Kilbourne ED; Pokorny BA; Johansson B; Brett I; Milev Y; Matthews JT
    J Infect Dis; 2004 Feb; 189(3):459-61. PubMed ID: 14745703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Squamous metaplasia of the lung alveolar epithelium in mice after influenza virus infection.
    Semkow R; Wilczyński J; Kruś S; Bogacka-Zatorska E
    Acta Virol; 1979 Nov; 23(6):497-9. PubMed ID: 44665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization with dissociated neuraminidase, matrix, and nucleoproteins from influenza A virus eliminates cognate help and antigenic competition.
    Johansson BE; Kilbourne ED
    Virology; 1996 Nov; 225(1):136-44. PubMed ID: 8918540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of protective and non-protective T cell epitopes in influenza.
    Crowe SR; Miller SC; Woodland DL
    Vaccine; 2006 Jan; 24(4):452-6. PubMed ID: 16140438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against avian influenza H9N2 virus challenge by immunization with hemagglutinin- or neuraminidase-expressing DNA in BALB/c mice.
    Qiu M; Fang F; Chen Y; Wang H; Chen Q; Chang H; Wang F; Wang H; Zhang R; Chen Z
    Biochem Biophys Res Commun; 2006 May; 343(4):1124-31. PubMed ID: 16580631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon induction by influenza virus: significance of neuraminidase.
    Chomik M
    Arch Immunol Ther Exp (Warsz); 1981; 29(1):109-4. PubMed ID: 6169320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses.
    Du N; Li W; Li Y; Liu S; Sui Y; Qu Z; Wang Y; Du Y; Xu B
    Vaccine; 2008 Jun; 26(23):2912-8. PubMed ID: 18448208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient vagina-to-lower respiratory tract immune trafficking in a murine model of influenza A virus infection.
    Garulli B; Meola M; Stillitano MG; Kawaoka Y; Castrucci MR
    Virology; 2007 May; 361(2):274-82. PubMed ID: 17222437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influenza hemagglutinin vaccine with poly(gamma-glutamic acid) nanoparticles enhances the protection against influenza virus infection through both humoral and cell-mediated immunity.
    Okamoto S; Yoshii H; Akagi T; Akashi M; Ishikawa T; Okuno Y; Takahashi M; Yamanishi K; Mori Y
    Vaccine; 2007 Nov; 25(49):8270-8. PubMed ID: 17977633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.